Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,321 | -19,190 |
| Depreciation Amortization | 361 | 480 |
| Accounts payable and accrued liabilities | -116 | 0 |
| Other Working Capital | -1,194 | -4,040 |
| Other Operating Activity | 702 | 1,010 |
| Operating Cash Flow | $-10,568 | $-21,740 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -14 | -10 |
| Purchase Sale Intangibles | -257 | 0 |
| Other Investing Activity | -257 | -170 |
| Investing Cash Flow | $-271 | $-180 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 6,781 | 0 |
| Debt Repayment | -1,072 | 0 |
| Other Financing Activity | -81 | 17,480 |
| Financing Cash Flow | $5,628 | $17,480 |
| Beginning Cash Position | 9,235 | 13,680 |
| End Cash Position | 4,024 | 9,230 |
| Net Cash Flow | $-5,211 | $-4,440 |
| Free Cash Flow | ||
| Operating Cash Flow | -10,568 | -21,740 |
| Capital Expenditure | -14 | 0 |
| Free Cash Flow | -10,582 | -21,740 |